Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1980-02-08
1981-11-10
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, 435 7, G01N 3348, G01T 100, G01N 3354
Patent
active
042998158
ABSTRACT:
An improved process for the determination of carcinoembryonic antigen in a sample of serum or plasma is disclosed. The improved process, in essence, comprises negating potentially interfering substances in the sample by diluting the sample with water and heating to a temperature below that which, at the ionic strength and pH of the sample, would cause coagulation of the proteins present and carrying out a radioimmunoassay for carcinoembryonic antigen on said sample.
REFERENCES:
patent: 3663684 (1972-05-01), Freedman et al.
patent: 3697638 (1972-10-01), Hansen
patent: 3867363 (1975-02-01), Hansen
patent: 4098876 (1978-07-01), Piasio et al.
patent: 4140753 (1979-02-01), Edgington et al.
patent: 4180499 (1979-12-01), Hansen
Hansen Hans J.
Myl Alfred D.
Vandevoorde Jacques P.
Gould George M.
Hoffmann-La Roche Inc.
Maitner John J.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Carcinoembryonic antigen determination does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carcinoembryonic antigen determination, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carcinoembryonic antigen determination will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2362382